Related Experiment Video
Updated: Aug 14, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Inhibition of the AT-Hook DNA-Binding Domain Attenuates HMGA2-Mediated Epithelial Mesenchyme Transition in Esophageal
Lucas de Jesus Lima1, Matheus Lohan-Codeço1, Maria Luísa Barambo Wagner1
1Laboratório de Interações Celulares, Instituto de Ciências Biomédicas, Programa de Pesquisa em Biologia Celular e do Desenvolvimento, Universidade Federal do Rio de Janeiro, Prédio do Centro de Ciências da Saúde-Cidade Universitária, Ilha do Fundão, Rua César Pernetta, 1766 (LS.3.01), Rio de Janeiro 21941-902, Brazil.
Abstract:
Esophageal squamous cell carcinoma (ESCC) is a highly prevalent malignancy worldwide. Moreover, ESCC remains poorly characterized at the molecular level, which contributes to limited therapeutic options and an overall poor prognosis. In this context, HMGA family members, which are overexpressed in tumors but almost absent in healthy adult tissues, seem to represent promising therapeutic targets. These proteins act by binding to AT-hook DNA-binding motifs and may regulate the expression of several genes associated with tumor progression. Therefore, integrating in silico, translational, and in vitro approaches, we investigated the functional consequences of blocking HMGA2-DNA interaction in ESCC tumor progression by using netropsin, a site-specific ligand for AT-rich DNA regions. Our results demonstrate that netropsin treatment significantly reduced cell viability, migration, and cell cycle progression, thereby promoting apoptosis. Furthermore, netropsin treatment was capable of partially reverting Epithelial-Mesenchymal Transition (EMT) activation associated with HMGA2 expression, by downregulating EMT activators, such as Slug and Twist. Finally, the netropsin treatment sensitizes ESCC cells to chemotherapeutic treatment with 5-Fluorouracil. Taken together, our findings highlight that AT binding-specific blockade could be correlated with the inhibition of HMGA2 and may reveal a promising approach to better understand ESCC progression.
Insights
Blocking HMGA2-DNA interactions with netropsin inhibits esophageal squamous cell carcinoma (ESCC) progression. This approach reduces cell viability, migration, and EMT, while enhancing apoptosis and sensitizing cells to chemotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Esophageal squamous cell carcinoma (ESCC) is a prevalent cancer with limited treatment options due to poor molecular characterization.
- HMGA proteins, overexpressed in tumors, are potential therapeutic targets due to their role in regulating genes associated with tumor progression.
- Targeting HMGA2-DNA interactions offers a novel strategy for ESCC treatment.
Purpose of the Study:
- To investigate the effects of blocking HMGA2-DNA interactions using netropsin on ESCC progression.
- To evaluate netropsin's impact on cell viability, migration, cell cycle, apoptosis, and Epithelial-Mesenchymal Transition (EMT).
- To assess the potential of netropsin in combination with 5-Fluorouracil chemotherapy.
Main Methods:
- In silico, translational, and in vitro approaches were employed.
- Netropsin, an AT-hook DNA-binding ligand, was used to block HMGA2-DNA interactions.
- Cell viability, migration, cell cycle, apoptosis, EMT markers (Slug, Twist), and response to 5-Fluorouracil were analyzed.
Main Results:
- Netropsin significantly reduced ESCC cell viability, migration, and cell cycle progression.
- Netropsin treatment promoted apoptosis in ESCC cells.
- Netropsin partially reverted EMT activation by downregulating Slug and Twist, and sensitized ESCC cells to 5-Fluorouracil.
Conclusions:
- Blocking HMGA2-DNA interactions with netropsin is a promising strategy for inhibiting ESCC progression.
- Netropsin demonstrates anti-cancer effects, including reduced proliferation, migration, and EMT, alongside enhanced apoptosis.
- Netropsin holds potential as an adjunct therapy to conventional chemotherapy for ESCC.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Mitogens and the Cell Cycle
Abnormal Proliferation
Hedgehog Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
